2021 ASCO Annual Meeting - Presentations on balstilimab differentiation and AGEN2373
June 4 - June 8, 2021
-
Title: Differentiated Activity Profile for the PD-1 Inhibitor balstilimab
Poster number: 5529
Poster Session: Gynecologic Cancer
Presenting author: Cailin Joyce, PhD
-
Title: Initial Findings of the First-in-human Phase I Study of AGEN2373, a Conditionally Active CD137 Agonist Antibody, in Patients (pts) With Advanced Solid Tumors
Poster number: 2634
Poster Session: Developmental Therapeutics - Immunotherapy
Presenting author: Anthony Tolcher, MD
Supporting Materials
ASCO2021 C.Joyce, et al. Poster 488.9 KB
ASCO21_Tolcher, et al. Poster 641.2 KB